---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-24-000794"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:45:35.374818+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Entera Bio regains Nasdaq minimum bid price compliance, delisting risk removed

## Summary
- Received Nasdaq notice on March 1, 2024 confirming bid price compliance.
- Ordinary shares closed at $1.00+ for 10 consecutive business days to satisfy rule.
- Listing matter is now closed; no further action required.
- Press release issued March 4, 2024 announcing the compliance.

## SEC filing metadata
- accession: 0001178913-24-000794
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891324000794/0001178913-24-000794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891324000794/zk2431079.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-24-000794
- JSON: https://secwatch.observer/filing/0001178913-24-000794.json
- Plain text: https://secwatch.observer/filing/0001178913-24-000794.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.